Holen Sie sich die Stockscreener-App
1.10
11.29%
-0.14
Handel nachbörslich:
1.14
0.04
+3.64%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.16
24-Stunden-Volumen:
2.94M
Relative Volume:
1.63
Marktkapitalisierung:
$178.68M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
27.50
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
-16.67%
1M Leistung:
+46.57%
6M Leistung:
-26.17%
1J Leistung:
-77.82%
1-Tages-Spanne:
$1.01
$1.18
1-Wochen-Bereich:
$1.01
$1.3488
52-Wochen-Spanne:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Vergleichen Sie IRWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.10 | 212.79M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Is Ironwood Pharmaceuticals Inc.’s growth already priced inWeekly Stock Report & Safe Entry Momentum Tips - khodrobank.com
Ironwood Pharma Regains Nasdaq Compliance - TipRanks
Ironwood Pharmaceuticals Inc. stock trendline breakdownQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Published on: 2025-09-03 06:20:24 - Newser
Published on: 2025-09-03 04:31:42 - Newser
Combining price and volume data for Ironwood Pharmaceuticals Inc.CEO Change & Short-Term Trading Opportunity Alerts - Newser
Is Ironwood Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
When is the best time to exit Ironwood Pharmaceuticals Inc.Portfolio Update Report & Low Drawdown Investment Strategies - Newser
Using Ichimoku Cloud for Ironwood Pharmaceuticals Inc. technicalsQuarterly Trade Summary & High Win Rate Trade Tips - Newser
Ironwood Pharmaceuticals Inc. stock chart pattern explainedEarnings Summary Report & Risk Managed Investment Signals - Newser
Is Ironwood Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Will Ironwood Pharmaceuticals Inc. stock recover after recent drop2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Will Ironwood Pharmaceuticals Inc. benefit from rate cuts2025 Buyback Activity & Safe Entry Zone Tips - khodrobank.com
Comparing Ironwood Pharmaceuticals Inc. in custom built stock radars2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Is Ironwood Pharmaceuticals Inc. likely to announce a buyback2025 Risk Factors & Low Drawdown Investment Ideas - خودرو بانک
Published on: 2025-09-02 07:32:33 - khodrobank.com
Should you hold or exit Ironwood Pharmaceuticals Inc. nowJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - Newser
Using data models to predict Ironwood Pharmaceuticals Inc. stock movementWeekly Profit Analysis & Technical Confirmation Alerts - Newser
What indicators show strength in Ironwood Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundExit Point & AI Driven Price Predictions - Newser
Published on: 2025-08-31 13:49:26 - beatles.ru
How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stockGold Moves & Safe Capital Investment Plans - Newser
RSI Reset May Fuel Rebound in Ironwood Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Options Data Show Bullish Bias in Ironwood Pharmaceuticals Inc.July 2025 Rallies & Safe Entry Trade Reports - beatles.ru
Analysts Spot Bullish Divergence in Ironwood Pharmaceuticals Inc.2025 Stock Rankings & Safe Capital Preservation Plans - beatles.ru
Analyzing drawdowns of Ironwood Pharmaceuticals Inc. with statistical toolsInsider Buying & Low Risk Entry Point Guides - Newser
Published on: 2025-08-29 17:20:59 - Newser
What are Ironwood Pharmaceuticals Inc.’s recent SEC filings showingDividend Hike & Free Technical Confirmation Trade Alerts - sundaytimes.kr
What earnings revisions data tells us about Ironwood Pharmaceuticals Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Measuring Ironwood Pharmaceuticals Inc.’s beta against major indices2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):